Abstract
Immunologically active lymphoid tissue in gut mucosa is preferentially programmed to inhibit autoimmune reactions, a property that can be exploited by oral administration of self-antigen. Identifying the target autoantigens to use in oral preparations may not be necessary. The trigger for oral tolerization is antigen-specific, but suppressive events in the target organ are nonspecific.